3.2. Altered PDK1 Expression Is Sufficient for the Deactivation of the PI3K/PDK/AKT/mTOR Oncogenic Signaling and Sensitizes Aggressive HCC Cells to Radiotherapy. This evidence concerns the gene AKT1 and hepatocellular carcinoma.